RecruitingPhase 1NCT07295951

A Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute Leukemia

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Janssen Research & Development, LLC
Principal Investigator
Janssen Research & Development, LLC Clinical Trial
Janssen Research & Development, LLC
Intervention
14C-bleximenib(drug)
Enrollment
10 target
Eligibility
18 years · All sexes
Timeline
20252026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07295951 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials